Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	803.10	50.20	-5.56
Graham Fair Price	-99.96	187.18	477463.96
PEG	-2295154054.79	-0.18	< 0.005
Price/Book	171869.83	1.58	< 0.005
Price/Cash Flow	246452.94	146.07	0.06
Prices/Earnings	517866.97	17.75	< 0.005
Price/Sales	248374.58	9.83	< 0.005
Price/FCF	246452.94	146.07	0.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-69.10	0.20	0.65
Operating Margin	20.56	0.18	-0.15
ROA	-66.20	0.01	0.04
ROE	0.07	0.02	-66.80
ROIC	-0.02	0.02	-14.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.03	53.78
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.77	1.85	141.07
EPS QOQ	4430.08	-1.00	-99.98
FCF QOQ	0.04	-0.29	643.72
Revenue QOQ	1.05	-0.30	-71.94
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	47.60	29.05	-38.98
Days Sales Outstanding (DSO)	30.56	51.83	69.63
Inventory Turnover	1.89	3.10	63.89
Debt/Capitalization	0.19	0.18	-4.95
Quick Ratio	39.71	1.61	-95.95
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	389038.61	264.69	-99.93
Cash	116198.04	87.54	-99.92
Capex	-3956.42	-2.03	99.95
Free Cash Flow	6024.74	2.86	-99.95
Revenue	90239.40	42.49	-99.95
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	39.71	1.77	-95.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.53	4.43	-19.91
Naive Interpretation	Member

06 - Financial Health · Weak

Rating